New Vitamin B12 Therapy Shows Promise Against Deadly Brain Cancer
Researchers have identified a modified form of vitamin B12, known as nitrosylcobalamin (NO-Cbl), that can cross the blood-brain barrier to target glioblastoma tumors. A study published in Oncoscience by Joseph A. Bauer of Nitric Oxide Services, LLC and the Cleveland Clinic Foundation Taussig Cancer Center found that this compound selectively accumulates in brain cancer tissue, … Read more